Titan Biotech Limited has scheduled a meeting of its Board of Directors on Saturday, May 30, 2026. The meeting will be held at the company's registered office in Delhi to discuss key financial agenda items for the financial year ended March 31, 2026.

The primary focus of the board meeting will be to consider and approve the audited financial results for the fiscal year, both standalone and consolidated. In addition to the financial results, the directors will evaluate and potentially recommend a dividend on equity shares for the financial year ended March 31, 2026, subject to the board's approval.

Trading Window Closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, Titan Biotech Limited has closed the trading window for designated persons. The closure is effective from Wednesday, April 1, 2026, and will remain in effect until 48 hours after the declaration of the board meeting's outcome on May 30, 2026.

Meeting Details

The board meeting will take place at 903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi-110034, India. The company has informed the stock exchanges regarding the schedule and the closure of the trading window.

Titan Biotech Limited has formally notified its shareholders of its participation in the second 100 Days Campaign — "Saksham Niveshak" — launched by the Investor's Education and Protection Fund Authority (IEPFA), Ministry of Corporate Affairs. The intimation, filed on May 06, 2026, follows an IEPFA circular dated March 27, 2026, requesting companies to roll out the campaign to help shareholders claim unpaid or unclaimed dividends.

About the Saksham Niveshak Campaign

The second phase of the "Saksham Niveshak – 100 Days Campaign" is scheduled to run from April 01, 2026 to July 09, 2026. The campaign's primary objective is to create awareness among shareholders and enable them to update their personal and financial details so that unclaimed dividends can be credited to their bank accounts before being transferred to the Investor Education and Protection Fund (IEPF).

Why Shareholders Need to Act

Since dividend on shares is payable only in electronic mode, dividends will be credited to a shareholder's bank account only after the relevant information and documents are updated. Shareholders are advised to update the following details with the company or its Registrar & Transfer Agent (RTA):

• PAN details
• Nomination details
• Contact information (postal address, mobile number)
• Bank account details
• Specimen signature

Shareholders holding shares in electronic form who have not claimed their dividend can do so by updating or modifying their details with their respective depository participants.

Required Forms and Submission Process

Shareholders are required to submit the following forms, available for download on the company's website at www.titanbiotechltd.com :

Physical copies of the completed forms are to be submitted to the company's RTA — M/s. Beetal Financial & Computer Services Private Limited ("Beetal") — at Beetal House, 3rd Floor, 99, Madangir, Behind Local Shopping Centre, Near Dada Harsukhdas Mandir, New Delhi – 110062.

Contact Information for Queries

Shareholders with queries regarding unpaid or unclaimed dividends or KYC updates may reach out through the following channels:

Shareholders are urged to submit all required documents before the campaign deadline of July 9, 2026 to ensure their unclaimed dividends are processed and credited accordingly.